18 Mar 2020

FDA REMOVES THE RED TAPE ON TEST DEVELOPERS MARCH 18

  Despite a decade of tightly regulating testing, the FDA is now allowing companies to proceed with their diagnostic tests for COVID-19 without first submitting them for federal review or obtaining an official emergency clearance. In the past, the FDA has warned of the personal health risks that could follow

0
14 Mar 2020

CORONAVIRUS IS UNLIKE ANYTHING IN OUR LIFETIME, AND WE HAVE TO STOP COMPARING IT TO THE FLU

   EDITOR’s NOTE: Longtime health reporter Charles Ornstein says that comparing the novel coronavirus to the flu is dangerously inaccurate. Not one public health expert he trusts has called that comparison valid. Here’s why. by Charles Ornstein   Is the United States Prepared for COVID-19? As a longtime health care

0
14 Mar 2020

ABOUT 4 IN 10 ADULTS IN THE U.S. ARE AT GREATER RISK OF DEVELOPING SERIOUS ILLNESS IF INFECTED WITH CORONAVIRUS

  Based on current understanding of risk, forty-one percent of adults ages 18 and older in the U.S. have a higher risk of developing more serious illness if they become infected with the virus that causes COVID-19, because they are older or have serious underlying health conditions, or both, according

0
14 Mar 2020

TRUMP, CMS TAKE ACTION TO FIGHT CORONAVIRUS NATIONAL EMERGENCY

  The Trump Administration announced on March 12 aggressive actions and regulatory flexibilities to help healthcare providers and states respond to and contain the spread of 2019 Novel Coronavirus Disease (COVID-19). The Centers for Medicare & Medicaid Services (CMS) is taking these actions following President Trump’s declaration of a national

0
11 Mar 2020

THROMBOLEX INC. BASHIR ENDOVASCULAR CATHETER FIH TRIAL RESULTS REPORTED AT AVF MEETING

    Thrombolex Inc., a medical device company focused on the design, development and manufacture of endovascular therapies for the treatment of arterial and venous thromboembolic disorders, has announced that its First-In-Human (FIH) trial confirms the early safety and feasibility of using the Bashir Endovascular Catheter for pharmaco-mechanical catheter-directed thrombolysis

0
06 Mar 2020

SIGVARIS GROUP CELEBRATES WORLD LYMPHEDEMA DAY MARCH 6

                SIGVARIS GROUP is participating in World Lymphedema Day today – March 6 — to spread awareness and support the continues search for a cure. World Lymphedema Day is an annual advocate-driven worldwide celebration established in 2016 by the US Senate in response to a bill written by

0
19 Feb 2020

INK RX? WELCOME TO THE CAMOUFLAGED WORLD OF PARAMEDICAL TATTOOS

      Doctors specialize in the science of healing, but tattoo artist Eric Catalano specializes in the art of it.   By Cara Anthony The first fingernail tattoo started off as a joke by a man who lost the tips of two fingers in a construction accident in 2018.

0
18 Feb 2020

GEOFF MARTHA TO REPLACE OMAR ISHRAK AT MEDTRONIC APRIL 27

       Geoff Martha, who leads Medtronic’s restorative therapies group and previously oversaw the company’s spine business, will succeed Omar Ishrak as president and CEO on April 27. Ishrak ‘s nearly 10-year tenure as chairman and CEO of Medtronic will come to an end when he retires April 26.

0
13 Feb 2020

SEVEN WAYS TO FALL IN LOVE AGAIN WITH YOUR HEALTHCARE JOB

              When most of us think of Valentine’s Day, we think about wine, roses, chocolates, and candlelit dinners in fancy restaurants. We think about love. What we don’t think about is work—especially when that work takes place in America’s healthcare system. (We’re likely to associate that with overloaded schedules,

0
12 Feb 2020

FDA OKs HYPERFINE’s BEDSIDE MRI

  The FDA has approved 510 (k) clearance for the Hyperfine Research Inc. bedside Magnetic Resonance Imaging (MRI) system, the world’s first bedside MRI. The Hyperfine system is 20 times lower cost, 35 times lower power consumption, and 10 times less weight than today’s fixed conventional MRI systems. Jonathan Rothberg,

0